Regeneron Therapy

Progressive Medical Center is now offering Regeneron (Regen-Cov) monoclonal antibody treatment for COVID-19. This therapy is administered via a subcutaneous injection with post injection patient monitoring required.

Regen-Cov is in high demand and all appointments are pending stock availability.

To protect our patients and staff, Progressive Medical has set up a Regeneron entrance separate from our main clinic and completely segregated away from our patients and staff. All staff are in full PPE and are required to follow strict CDC guidelines to prevent the spread of the virus. No staff member who administered Regeneron is allowed to enter our main building.

What is Regen-Cov?

Regeneron (Regen-Cov) is a Monoclonal Antibody cocktail, combining 2 types of Antibodies that are explicitly designed to block the infectivity of the Corona Virus that causes Covid-19.

Regeneron is the first antibody therapy to demonstrate the antiviral effect in patients with Covid-19.

The FDA has issued an Emergency Use Authorization (EUA) for Regen-Cov for the treatment of mild to moderate COVID-19 and post-exposure prophylaxis (prevention) of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization as well

In short, there are treatment options available for the treatment, and prevention (for post exposure), of Covid-19.

Our body naturally creates Antibodies in response to all viruses. Once you get a virus, your body responds to creates antibodies specifically designed to neutralize that Virus. Your body’s adaptive immune system is based in large part on this process. Monoclonal Antibodies have been developed to catalyze your body’s natural response to stop the spread and progression of viruses.

Watch this Video on how Monoclonal Antibodies work.

How is this therapy administered?

Regen-Cov can be administered as an IV infusion or via subcutaneous injection. The subcutaneous injection is a series of 4 separate injections in the abdomen. The injections take minutes and are non-invasive and easy. The injections are followed by a 1 hour monitoring to ensure no reactions occur. Reactions are very rare and mild but we take all precautions to ensure the safety of our patients. The monitoring phase take place from the patients car and a medical team member check on patients regularly

Is there a cost for this therapy?

Most insurance companies, including Medicare and Medicaid,  will cover the cost of this treatment, subject to normal policy exclusions.  There are also provisions in the CARES act for uninsured individuals to receive this treatment with no out of pocket costs.

Who is a candidate for this therapy?

You must be 65 years or older OR are between the ages of 12 and 64 years AND have any of the following conditions:

  • Chronic Kidney Disease
  • Diabetes
  • Heart Disease/Hypertension
  • Lung Disease (COPD/Emphysema, Asthma, Interstitial Lung Disease, etc.)
  • Neurodevelopmental Disorders (Cerebral Palsy, etc.)
  • Medical Devices (Tracheostomy, Gastrostomy Tube, etc.)
  • Sickle Cell Disease
  • Pregnancy
  • Obesity BMI >25 kg/m2 or, for those ages 12-17, BMI > 85th percentile for their age and gender based on CDC growth charts

In Addition, according to the CDC, individuals with the following may also be high risk and are a candidate for this therapy: autoimmune diseases, cancer, certain ethnic groups, low income (Long-standing systemic health and social inequities ), hyperlipidemia, and unvaccinated (not fully vaccinated) or who are not expected to mount an adequate immune response to complete SARS-CoV-2 vaccination (for example, individuals with immuno-compromising conditions including those taking immunosuppressive medications2 ) and – have been exposed to an individual infected with SARS-CoV-2 consistent with close contact criteria per Centers for Disease Control and Prevention (CDC)3 or – who are at high risk of exposure to an individual infected with SARSCoV-2 because of occurrence of SARS-CoV-2 infection in other individuals in the same institutional setting.

If you have any questions about this therapy, including if you may be a candidate, Contact Us to learn more.

鶴橋ブランドコピー スーパーコピー ブランドコピー コピーブランド ロレックス スーパーコピー ロレックス コピー モンクレール スーパーコピー モンクレール コピー モンクレール ダウン コピー シュプリーム スーパーコピー シュプリーム コピー ウブロ スーパーコピー ウブロ コピー ルイヴィトン スーパーコピー ルイヴィトン コピー ブランドiphoneケースコピー グッチ スーパーコピー
鶴橋ブランドコピー スーパーコピー ブランドコピー コピーブランド ロレックス スーパーコピー ロレックス コピー モンクレール スーパーコピー モンクレール コピー モンクレール ダウン コピー シュプリーム スーパーコピー シュプリーム コピー ウブロ スーパーコピー ウブロ コピー ルイヴィトン スーパーコピー ルイヴィトン コピー ブランドiphoneケースコピー グッチ スーパーコピー